Upgrade to SI Premium - Free Trial

Mizuho Securities Raises Price Target on Quest Diagnostics (DGX) Following In-Line 1Q Results

April 21, 2016 2:16 PM
Mizuho Securities reiterated an Outperform rating on Quest Diagnostics (NYSE: DGX), and raised the price target to $84.00 (from $75.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles